SAFESOFT

As the first domestic e-clinical trial solution encompassing all areas from specimen analysis to clinical Phase 3, we possess transformation tools that fully support the Standard for Exchange of Nonclinical Data (SEND) dataset, which is required for submission to the U.S. FDA